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Mycobacteria use type VII secretion systems to secrete pro-
teins across their highly hydrophobic diderm cell envelope.
Pathogenic mycobacteria, such as Mycobacterium tuberculosis
and Mycobacterium marinum, have up to five of these systems,
named ESX-1 to ESX-5. Most of these systems contain a set of
five conserved membrane components, of which the four Ecc
proteins form the core membrane-embedded secretion com-
plex. The fifth conserved membrane protein, mycosin protease
(MycP), is not part of the core complex but is essential for secre-
tion, as it stabilizes this membrane complex. Here we investi-
gated which MycP domains are required for this stabilization by
producing hybrid constructs between MycP1 and MycP5 in
M. marinum and analyzed their effect on ESX-1 and ESX-5
secretion. We found that both the protease and transmembrane
domain are required for the ESX system-specific function of
mycosins. In addition, we observed that the transmembrane
domain strongly affects MycP protein levels. We also show that
the extended loops 1 and 2 in the protease domain are probably
primarily involved in MycP stability, whereas loop 3 and the
MycP5-specific loop 5 are dispensable. The atypical propeptide,
or N-terminal extension, is required only for MycP stability.
Finally, we show that the protease domain of MycPP1, encoded
by the esx-P1 locus on the pRAW plasmid, is functionally redun-
dant to the protease domain of MycP5. These results provide the
first insight into the regions of mycosins involved in interaction
with and stabilization of their respective ESX complexes.
Mycobacteria, including Mycobacterium tuberculosis, have a
set of specialized secretion systems, called type VII secretion
(T7S)2 systems, to secrete proteins across their highly hydro-
phobic cell envelope (1). This group of bacteria contains up to
five genomic clusters coding for these T7S systems, named
ESX-1 to ESX-5 (1, 2). Three of these systems, ESX-1, ESX-3,
and ESX-5, have been shown to be functional and to play critical
roles in virulence and bacterial physiology (3–6). The ESX-1
system is required for phagosomal rupture both in M. tubercu-
losis and Mycobacterium marinum (3, 7, 8), and is therefore a
crucial factor for completing the intraphagocytic stage of these
pathogens. The importance of ESX-1 for virulence is further
illustrated by the absence of the esx-1 region in the live vaccine
strain Mycobacterium bovis BCG (4). The ESX-3 and ESX-5
systems have very different functions, as they have been linked
to iron and fatty acid uptake, respectively (5, 6, 9). Because of
their role in metabolite and nutrient uptake, both of these sys-
tems are essential for in vitro growth in pathogenic species.
However, the essentiality of the ESX-5 system can be circum-
vented in M. marinum by permeabilizing the unique mycobac-
terial outer membrane, either by mutating genes involved in the
biosynthesis of the outer membrane lipid phthiocerol dimyco-
cerosate or by the introduction of MspA, an outer membrane
porin from the nonpathogenic Mycobacterium smegmatis (6).
In the last decade, information has been obtained about the
composition of the membrane-embedded ESX complexes (10,
11) and the structure and (possible) functioning of several of its
components, e.g. of EccB, EccC, and EccD (12, 13). This has
recently seen a strong leap forward with the first structure of
the core ESX-5 secretion complex of Mycobacterium xenopi,
imaged by negative-stain EM (14). From the observed 6-fold
symmetry together with stoichiometry measurements, it can be
deduced that the ESX-5 complex consists of six copies of each
of the four conserved membrane components that make up the
complex, i.e. EccB5, EccC5, EccD5, and EccE5 (14). The data on
the M. xenopi ESX-5 complex match the composition deter-
mined previously for the ESX-1 and ESX-5 systems of M. mari-
num and the ESX-5 system of M. bovis BCG by protein pull-
down experiments (10, 11). Notably, the fifth membrane
component, the mycosin protease (MycP), was not detected in
significant amounts in any of these purified complexes. Despite
this, mycosins are essential for the proper functioning of the
ESX-1 and ESX-5 systems, as mycP1 or mycP5 knockouts result
in a secretion deficiency by the respective systems in different
species (11, 15), and transposon mutagenesis experiments indi-
cate that MycP3 is also essential in M. tuberculosis (16, 17). Fur-
thermore, mycosins are widely conserved in T7S, not only in all
mycobacterial ESX systems but also in T7S clusters of other
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Actinobacteria, suggesting that they have a critical function in
T7S (18, 19). Recently, we showed that both MycP1 and MycP5
stabilize their respective ESX complexes in M. marinum,
explaining their essentiality for T7S in mycobacteria (11).
Mycosins belong to the family of subtilisin-like serine pro-
teases, and the available crystal structures indeed show a
subtilisin-like fold (20, 21). However, there are also some differ-
ences from classical subtilisins, most prominent for the
so-called propeptide. Although subtilisins contain an N-termi-
nal propeptide that blocks the active site, which is cleaved off
upon protein maturation to activate the protease, for mycosins,
this N-terminal extension is not processed but remains part of
the mature protease domain. Furthermore, this extension is not
blocking the substrate binding pocket but is elongated and
tightly wrapped around the protease domain (20 –22). As the
N-terminal region of mycosins does not contain any of the typ-
ical characteristics of a propeptide (22), we refer to it as the
N-terminal extension (NE) of mycosins in this study. Com-
pared with typical subtilisins, the mycosins have a deeper
active-site groove because of the presence of the N-terminal exten-
sion in the mature protein and three extended loops that surround
the active site (20, 21). This suggests that mycosins have a higher
substrate selectivity compared with most subtilisin-like proteases.
Finally, mycosins also have a C-terminal transmembrane (TM)
domain, connected to the protease domain by an 28-amino-ac-
id-long linker region. Because of the presence of a typical signal
sequence preceding the N-terminal extension and a positively
charged short C-terminal tail, the protease domain is predicted to
be localized in the periplasm.
So far, the number of identified substrates of mycosins is
extremely limited. Only MycP1 has been shown to cleave the C
terminus of EspB, one of the substrates of the ESX-1 system, in
M. tuberculosis and M. marinum (11, 15). Surprisingly, the pro-
teolytic activity of MycP1 is not required for the essential func-
tion of this protein in secretion (11, 15). Also, an active-site
mutant of mycP5 can still mediate ESX-5 secretion in M. mari-
num (11). This discrepancy suggests that the second essential
function of mycosins is not dependent on their proteolytic
activity. As already mentioned, mycosins are involved in stabi-
lization of their respective ESX complex without having a role
in complex assembly (11). This conclusion is based on the
observation that we could detect the ESX-1 or ESX-5 complex
in a mycP1 or mycP5 knockout, respectively, when we cross-
linked cell envelope fractions prior to detergent extraction of the
membrane-embedded ESX complexes (11). Therefore, the ESX
complex is apparently formed in the absence of mycosin but dis-
associates rapidly upon detergent extraction. The proteolytic
activity of MycP is not required for this function, as an active site
mutation did not affect the stabilizing effect of MycP1 or MycP5 on
its respective ESX complex (11). However, the MycP domain
responsible for this function has yet to be identified.
Here we set out to identify the domains of MycP1 and MycP5
that are involved in the essential role of mycosins in T7S in
M. marinum by producing specific truncated versions and
hybrid proteins in which individual domains of MycP1 and
MycP5 were exchanged. Our results show that the N-terminal
extension is required for structural integrity, whereas both the
protease and TM domains of MycP1 and MycP5 are system-
specific and essential for the functionality of their respective
ESX complexes. By further dissecting the protease domain, we
found that the primary function of the extended loops is not
related to the stabilization of the membrane complex. Finally, we
show that the protease domain of MycPP1 of the plasmid-encoded
ESX-P1 system can complement the function of the protease
domain of MycP5. This study provides important functional
insights into the different domains of the mycosin proteases.
Results
The N-terminal extension and the TM domain are essential for
mycosin functioning
To determine which domains are involved in the essential
function of mycosins in T7S, we produced mycP1 and mycP5
truncations in which either the NE or the TM domain was
removed (Figs. 1A and 2A) and analyzed their functionality in
the previously described mycP1 and of mycP5 knockout strains
of M. marinum (11). To be able to dissect the functionality of
the different MycP5 constructs in ESX-5 secretion, the essenti-
ality of ESX-5 for in vitro growth was alleviated by introduction
of the outer membrane porin MspA (6, 23). As reported previ-
ously (11, 15), knockout of both mycP1 and mycP5 resulted in
complete secretion deficiency by their respective ESX systems.
We showed this deficiency by the absence of the ESX-5 sub-
strate group of PE_polymorphic GC-rich repetitive sequences
(PGRS) proteins in the pellet and supernatant for the mycP5
knockout (Fig. 1C, lanes 2 and 12) and the absence of the ESX-1
substrates EsxA and EspB in the supernatant fraction of the
mycP1 knockout (Fig. 2C, lane 12). The secretion by the
mutants can be complemented by exogenous expression of
their respective WT copies bearing a C-terminal HA tag for
detection (Figs. 1C, lane 13, P5, and 2C, lane 13, P1). As
expected, secretion could not be restored by exogenous expression
of MycP1 in the mycP5 knockout strain and vice versa (Figs. 1C,
lane 14, and 2C, lane 14). An additional observation was that,
although MycP5 is larger than MycP1, the HA signal for MycP5
showed a lower molecular weight compared with MycP1 (Fig. 1B,
lanes 3 and 4, P1 and P5). Based on the size of the detected frag-
ment (37 kDa), we concluded that MycP5 is processed some-
where in its protease domain, which we will discuss further below.
Next we determined the effect of deleting the N-terminal
extension of MycP5 (P5NE) and MycP1 (P1NE). We found
that, for both MycP5 and MycP1, this deletion resulted in com-
plete loss of protein secretion by their respective ESX systems
(Figs. 1C, lane 15, and 2C, lane 15). In addition, although we could
readily detect HA-tagged WT MycP5 and MycP1 in bacterial pellet
fractions, we were unable to detect these truncated proteins via the
same C-terminal HA tag in the same bacterial fraction (Figs. 1B,
lane 5, and 2B, lane 5), suggesting that the N-terminal extension
of mycosins is required for protein stability.
Although deletion of the NE reduced the stability of myco-
sins, removing the C-terminal TM domain resulted in a strong
increase in mycosin levels compared with their WT versions.
Although this effect was observed for both MycP5 and MycP1,
especially in the case of MycP1TM, the increase in HA signal
was of such intensity that the other hybrid constructs were not
or barely detectable without overexposing the MycP1TM sig-
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nal (Figs. 1B, lane 6, P5TM, and 2B, lane 6, P1TM). There-
fore, we included an additional immunoblot lacking the trun-
cated MycP1 construct to allow more accurate comparison with
WT MycP1 or MycP5 (Fig. S1). Interestingly, for the MycP5
truncate, besides the C-terminal portion of 37 kDa, an 65 kDa
band could be detected, which probably represented the unpro-
cessed full-length protein. However, although present at high lev-
els, the mycosin constructs lacking the TM domain were unable to
complement ESX secretion of their respective knockouts (Figs. 1C,
lane 16, and 2C, lane 16). Furthermore, expressing the highly sta-
ble truncated MycP5TM did not result in a dominant-negative
effect on ESX-5–mediated secretion in WT bacteria (Fig. S2).
These results show that both the N-terminal extension and the
C-terminal TM domain are required for the essential function of
mycosins within their respective ESX systems.
Both the protease and TM domain of MycP1 and MycP5 are ESX
system–specific
To distinguish between a general role in protein stability (for
the N-terminal extension) or subcellular localization (for the
TM domain) and a system-specific function of the separate
domains, we created hybrid mycP1 and mycP5 constructs in
which individual domains were exchanged between the two
mycosins, again with a C-terminal HA tag for detection (Figs.
1A and 2A). As deletion of the N-terminal extension resulted in
a strong decrease in mycosin levels, we first wanted to confirm
whether this domain is only involved in structural stability and
does not play a system-specific role. Indeed, although we did
observe a decrease in mycosin levels when we exchanged this
domain between MycP5 and MycP1 (Figs. 1, A and B, lane 7,
P5NE1 and 2, A and B, lane 7, P1NE5, and Fig. S1, lane 5), both
constructs were still able to complement ESX-5 or ESX-1 secre-
tion of the mycP5 and mycP1 knockouts, respectively (Figs. 1C,
lane 17, and 2C, lane 17). With a similar approach, we
exchanged the C-terminal TM domain of the mycosins to
investigate whether they have a system-specific role. Although
we observed decreased expression of MycP5 with the TM
domain of MycP1 (Fig. 1B, lane 8, P5TM1), the opposite MycP1
construct showed substantial expression levels (Fig. 2B, lane 8,
P1TM5, and Fig. S1, lane 6). Both constructs were unable to
complement secretion by mycP5 or mycP1 knockout (Figs. 1C,
lane 18, and 2C, lane 18), strongly suggesting that the TM
domain of mycosins does not only function as a membrane anchor
but that it has a specific function for its ESX system. Interestingly,
we also tested whether all constructs were able to alleviate the
essentiality of mycP5, i.e. by mediating growth in the absence of the
Figure 1. A, schematic overview of (hybrid or truncated) mycP5 (blue) and mycP1 (purple) constructs used to complement a mycP5 knockout in M. marinum. The
constructs contain the following parts: SS, signal sequence; NE, N-terminal extension; Protease, protease domain (including the linker region between the
protease and TM domain); TM, transmembrane domain (including the short C-terminal tail). The numbers indicate the origin of the fragment, i.e. 1 for MycP1
and 5 for MycP5. The exact residues of the swapped domains are indicated in Fig. S4. In addition, all proteins have a C-terminal HA tag. B, immunoblot detection
of the HA-tagged constructs expressed in the mycP5 knockout. MW, molecular weight. C, immunoblot analysis of cell pellets and supernatants of WT M. mari-
num and a mycP5 knockout, complemented with the constructs depicted in A. Proteins were visualized with anti-PE_PGRS (ESX-5 substrates), anti-EsxA (ESX-1
substrate, supernatant loading control), and anti-GroEL2 (cytosolic loading control).
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outer membrane porin MspA (Table S2). All constructs that could
complement protein secretion also supported growth of the mycP5
mutant in the absence of MspA. Although P5TM1 was unable to
restore ESX-5 secretion in the mycP5 knockout, this construct did
allow this mutant strain to grow, albeit with a strongly reduced
growth rate. This suggests that this hybrid construct is able to
complement the mycP5 mutant to some extent.
Finally, we determined whether the protease domain is also
involved in the essential function of mycosins by introducing
the hybrid constructs in the opposite mycP knockout, e.g.
P1NE5 and P1TM5 in the mycP5 knockout and vice versa (Figs.
1A and 2A). These constructs were also unable to complement
the mycosin knockouts and were thus unable to restore secre-
tion of the analyzed ESX systems (Figs. 1C, lanes 19 and 20, and
2C, lanes 19 and 20). As we already showed that exchanging
the N-terminal extension has no effect on the functionality of
MycP1 or MycP5, the inability of P1TM5 and P5TM1 to com-
plement the mycP5 and mycP1 knockout, respectively, must be
contributed to the exchanged protease domain. In conclusion,
although the N-terminal extension has a system-specific func-
tion in protein stability, both the protease and C-terminal TM
domain of mycosins are required and specific for essential func-
tion within their respective ESX systems.
The extended loops of the protease domain are either dispens-
able or involved in structural stability
Next we set out to identify specific regions within the prote-
ase domain that are involved in the essential function of myco-
sins. A distinctive feature of mycosins compared with classical
subtilisins is three extended loops that are present in the pro-
tease domain (loops 1–3) (Fig. 3A). In addition to these three
conserved loops, MycP5 has an additional large extension to
which we will refer as loop 5 in this study. This loop is not
present in MycP1. In a structural model of MycP5, produced
from the available MycP1 structure from M. smegmatis (20),
loop 5 remained unstructured, and we therefore only show the
start and end of it in the model shown in Fig. 3A. Because loops
1–3 and loop 5 are unique for mycosins, we hypothesized that
they could be involved in the essential function of mycosins. By
individually deleting these four loops of MycP5, we investigated
their effect on stability and/or functionality. Deleting loop 1 or
2 resulted in reduced stability of MycP5; especially loop 2 dele-
tion showed almost complete loss of MycP5 stability (Fig. 3B).
In addition, both constructs resulted in complete loss of ESX-5
secretion (Fig. 3C, lanes 13 and 14). In contrast, deleting loop 3
or loop 5 had little to no effect on MycP5 stability or on ESX-5
Figure 2. A, schematic overview of (hybrid or truncated) mycP1 (purple) and mycP5 (blue) constructs used to complement a mycP1 knockout in M. marinum. All
constructs contain a C-terminal HA tag. See Fig. 1A for an explanation of the abbreviated domains. B, immunoblot detection of the HA-tagged constructs,
expressed in the mycP1 knockout. MW, molecular weight. C, immunoblot analysis of cell pellets and supernatants of WT M. marinum and a mycP5 knockout,
complemented with the constructs depicted in A. Proteins were visualized with anti-EsxA and anti-EspB (ESX-1 substrates), anti-PE_PGRS (ESX-5 substrates,
supernatant loading control), and anti-GroEL2 (cytosolic loading control).
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secretion (Fig. 3, B, lanes 6 and 7, and C, lanes 15 and 16).
Interestingly, deleting loop 5 resulted in a higher detected
molecular weight compared with the WT HA-tagged MycP5
(Fig. 3B, lanes 3 and 7), indicating that MycP5 is cleaved some-
where in this loop and that this processing is not required for
proper functioning. To investigate whether this processing is
performed by MycP5 or by a different component of the
ESX-5 system, we introduced both a WT and an active-site
mutant variant of HA-tagged MycP5 in M. smegmatis, which
lacks the ESX-5 system. However, we found that, in both
cases, MycP5 was present as the processed form, showing
that the responsible protease is unrelated to the ESX-5 sys-
tem (Fig. S3C).
Subsequently, we analyzed the role of loop 1 and 2 in protease
activity using the ability of purified MycP1 to process its sub-
strate EspB in vitro. Although we were unable to produce stable
MycP1 with the deletion of loop 2, deletion of loop 1 resulted in
substantial expression of the MycP1 protease domain. This
purified protein was also active, as we could not detect a differ-
ence in the activity of purified WT MycP1 compared with the
loop 1 truncation; in both cases, EspB was successfully pro-
cessed in vitro (Fig. S3D, lanes 2 and 3, P1 and P1L1). Finally,
we exchanged the loop 1 of full-length MycP5 with the loop of
MycP1 and analyzed its expression and functionality in the mycP5
knockout strain. This hybrid protein was stable (Fig. S3A, lane 4,
P5-L1.P1) and resulted in successful complementation of ESX-5
secretion (Fig. S3B, lane 8). Together, the results show that,
although loop 3 and loop 5 are dispensable for MycP5 stability and
its essential role in ESX-5 functioning, loop 1 and 2 seem to have a
structural role, similar to the N-terminal extension.
The protease domain of MycP5 can be functionally substituted
by the protease domain of MycPP1 of the plasmid-encoded
ESX-P1 system
As we were unable to obtain further functional insight from
analysis of the extended loops in MycP5, and as there are no
other distinctive regions or structures within the protease
domain, we looked for a different approach. More recently,
Figure 3. A, model of MycP5, based on the available crystal structure of MycP1. The catalytic triad of the protease is depicted in red, and the three extended loops
(1–3) surrounding the catalytic groove are depicted in blue, yellow, and green, respectively. The two residues bordering the extended loop 5 are depicted in
orange, whereas loop 5 itself is not shown in this model. B, immunoblot detection of HA-tagged constructs expressed in the mycP5 knockout. P5, WT mycP5;
P5Loop1/2/3/5, mycP5 without loop 1, 2, 3, or 5; P.P1, mycPP1; P.P1-TM5, hybrid mycPP1 with the TM region of mycP5. The exact residues of the deleted and
swapped regions are indicated in Fig. S4. MW, molecular weight. C, immunoblot analysis of cell pellets and supernatants of WT M. marinum and a mycP5
knockout, complemented with (truncated) mycP5 constructs or (hybrid) mycPP1 with the TM region of mycP5 (see Fig. S4 for the swapped residues). Proteins
were visualized with anti-PE_PGRS (ESX-5 substrates), anti-EsxA (ESX-1 substrate, supernatant loading control), and anti-GroEL2 (cytosolic loading control).
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plasmid-localized esx clusters have been described for myco-
bacteria, most notably the esx-P1 cluster localized on the
pRAW plasmid found in M. marinum E11 (24), involved in bac-
terial conjugation. Interestingly, the ESX-P1 system is most
closely related to the ESX-5 system, e.g. MycPP1 has 59.5%
identity to MycP5 (Fig. S4 and Table S1), which is substantially
higher than the identity of MycP5 to MycP1 (46%, Table S1).
Because of this high sequence similarity, we set out to investi-
gate to what extent mycPP1 is able to complement the mycP5
knockout of M. marinum M, which does not contain the esx-P1
cluster. Unfortunately, we were able to detect only low protein
levels of the HA-tagged MycPP1 (Fig. 3B, lane 8, P.P1), and this
construct did not result in successful complementation of the
mycP5 knockout (Fig. 3C, lane 17). In addition to this, the HA
signal of the MycPP1 protein showed a comparable size as that
of MycP5 (Fig. 3B, lane 3), indicating that MycPP1 is also pro-
cessed, which is in line with the observation that this protein
contains a loop 5 extension similar to MycP5 (Fig. S4). As we
already determined that the TM domain plays an important
role, we exchanged the TM domain of MycPP1 with that of
MycP5. Interestingly, this not only resulted in a substantially
more stable protein (Fig. 3B, lane 9, P.P1-TM5), but it was also
capable of restoring ESX-5 secretion in the mycP5 knockout
(Fig. 3C, lane 18). These results show that the protease domain
of MycPP1 has functional similarity to that of MycP5 and further
strengthens the notion that the TM domain of mycosins has a
highly system-specific function.
The protease and TM domain of MycP are both involved in
stabilization of the ESX complex
To further confirm that the essential role of the protease and
TM domain is linked to the previously determined crucial role
of mycosins in the stabilization of their respective ESX complex
(11), we investigated the effect of expressing our hybrid con-
structs in the mycP5 knockout on the ESX-5 membrane com-
plex. First, we established that there were no effects of our
introduced constructs on the production or stability of EccB5,
one of the components of the ESX-5 membrane complex (Fig.
4A). Next we investigated the stability of the ESX-5 membrane
complex. As shown previously (11), the 1.8-MDa ESX-5 com-
plex could be solubilized in a stable form from the WT strain
and visualized by blue native PAGE, whereas solubilized com-
plex levels were strongly reduced in the mycP5 knockout (Fig.
4B, lanes 1 and 2). Exchanging either the TM or protease
domain of MycP5 with that of MycP1 (P5TM1 and P1TM5) did
not restore stability of the ESX-5 complex in the mycP5 knock-
out (Fig. 4B, lanes 4 and 5), which was expected, as these con-
structs were also unable to successfully restore secretion (Fig.
1C). In contrast to this, although MycPP1 was unable to com-
plement secretion, we were able to detect a slight increase in
ESX-5 complex levels when we introduced MycPP1 (Fig. 4B,
lane 6, P.P1). Complementation of the hybrid MycPP1 con-
struct with the TM domain of MycP5 resulted in full restoration
of the ESX-5 complex to WT levels (Fig. 4B, lane 7, P.P1-TM5).
In conclusion, our results show that the crucial and system-
specific role of both the protease and TM domain of mycosins
in ESX secretion is consistently linked to the stabilization of
their respective ESX complex.
Discussion
Mycosin is an enigmatic component of the T7S system, as it
is a highly conserved and essential component of this system,
but its protease activity is dispensable for secretion. Although
we were previously able to assign the essential role of mycosins
to stabilizing the secretion complex in the mycobacterial cell
envelope, the specific mycosin domains involved in this sta-
bilization remain unknown. Here we set out to obtain insight
into the role of individual mycosin domains in this process
by producing various domain deletions and hybrid mycosin
constructs.
It has been shown previously that the N-terminal extension,
called the propeptide in subtilisins, is not processed but
remains tightly wrapped around the protease domain of myco-
sins (20, 21). In line with this, our results also strongly suggest
that the extension solely has a structural role, as it is able to
stabilize protease domains of mycosins from different ESX sys-
Figure 4. A, immunoblot analysis of solubilized cell envelope fractions of WT M. marinum and a mycP5 knockout, complemented with WT mycP5 (P5), hybrid
constructs of mycP5 with the TM region of mycP1 (P5TM1) or mycP1 with the TM region of mycP5 (P1TM5), WT mycPP1 (P.P1), and a hybrid construct of mycPP1 with
the TM region of mycP5 (P.P1-TM5). Proteins were visualized with anti-EccB5 and, as loading controls, anti-EccB1 and anti-FtsH. B, blue native PAGE immunoblot
analysis of solubilized cell envelope fractions; the ESX-5 complex was visualized with anti-EccB5.
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tems (Figs. 1B, lane 7, P5NE1, and 2B, lane 7, P1NE5). This is
further supported by a study by Sun et al. (22), who showed that,
although the structural conformation of the protease domain of
MycP1 is not altered by deleting the extension, molecular
dynamics simulations did show increased flexibility, suggesting
decreased stability of the protease domain. This can be
explained by the presence of stabilizing interactions between
these two domains, i.e. an anti-parallel -sheet and a disulfide
bond. The decreased stability is apparently more severe during
in vivo expression in M. marinum (Figs. 1B, lane 5, P5NE, and
2B, lane 5, P1NE) compared with the MycP1 purified from
Escherichia coli by Sun et al. (22).
Our results clearly show that both the protease and TM
domain are essential and function in a system-specific manner
in ESX-mediated secretion and stabilization of the ESX com-
plex (Figs. 1, 2, and 4). However, the importance and role of the
TM domain appears to be complicated. Although it is clearly
required for secretion and ESX-5 complex stability, the hybrid
MycP5 construct with the TM domain of MycP1 (P5TM1) did
remove the requirement for MspA in the mycP5 knockout, sug-
gesting that the TM domain of MycP1 is able to take over the
role of the equivalent domain of MycP5 to a minor extent. A
possible role of the TM domain is to properly localize mycosins
to their respective ESX complex by a specific interaction with
this membrane complex. Thus, we postulate that a small sub-
population of P5TM1 is still capable of interacting with the
ESX-5 complex, possibly only by the protease domain, whereas
TM1 only serves as a membrane anchor. This results in a very
limited level of functional ESX-5 complexes, showing that this
strain is capable of (very limited) growth in the absence of
MspA. In addition to this, the expression levels of mycosins
seem to be highly influenced by the presence and nature of the
TM domain. Although its deletion strongly increased protein
levels, exchange of TM domains in the hybrid constructs also
affected protein levels; e.g. constructs with the TM domain of
MycP5 generally resulted in higher protein levels irrespective of
the identity of the protease domain. Especially the increased
stability of mycosin in the absence of a TM domain is intriguing,
as it suggests that WT mycosin is a relatively unstable protein.
The question is then whether a high turnover is somehow
related to its function.
In contrast to the TM domain, the protease domain of MycP5
is absolutely required for ESX-5–mediated secretion and stabi-
lization of the ESX-5 membrane complex, a role that cannot be
replaced by the protease domain of MycP1. The essential role of
the protease is not related to its protease activity, as we and
others showed previously that active-site mutants in MycP1 and
MycP5 are fully able to mediate secretion and membrane com-
plex stability of the respective systems (11, 15). We therefore
tried to further dissect the specific features of MycP5 that
are essential for ESX-5 secretion by deleting its distinctive
extended loops in the protease domain. However, none of the
loops appear to be involved in the essential and system-specific
function. Notably, deletion of loop 2 results in a strong reduc-
tion of MycP5 levels (Fig. 3B, lane 5), and as this is also the most
strongly conserved loop (Table S1), we expect it to play a struc-
tural role in, e.g., establishing a stable protein conformation.
This is also supported by the observation that we were unable to
produce stable MycP1 lacking loop 2 in E. coli and the presence
of a cysteine residue, which forms a disulfide bridge with the
core protease structure (20, 21). However, as we were still able
to detect low levels of MycP5 lacking loop 2 in M. marinum, we
cannot exclude that it is involved in the system-specific func-
tioning of MycP5. In addition to this, although deleting loop 1
also resulted in lower expression levels and an ESX-5 secretion
defect, MycP5 with loop 1 of MycP1 is fully functional, showing
that this loop is not involved in the system-specific functioning
of the protease. Deleting loop 1 in MycP1 did not affect protease
activity in vitro, suggesting that this loop is also not directly
involved in substrate recognition. These combined results sug-
gest that loop 1 and loop 2 have a general structural role in
mycosins. In contrast, loop 3 and loop 5 can be removed in
MycP5 without affecting protease integrity and ESX-5 func-
tionality. Interestingly, MycP5 and MycPP1 appear to be pro-
cessed in the larger loop 5, which is not conserved in all myco-
sins (e.g. Fig. S4). The two resulting MycP fragments are
expected to form a single stable unit because of the structural
requirement of the N-terminal extension (Figs. 1B, lane 5,
P5NE, and 2B , lane 5, P1NE). The observed cleavage is not
an autoproteolytic process; it is not dependent on either pro-
teolytic active MycP5 or on a functional ESX-5 system, as we
also observed this processing when we expressed HA-tagged
MycP5 and a corresponding HA-tagged active site mutant in
M. smegmatis that lacks ESX-5 (Fig. S3C). In addition, for the
MycP5 construct with the TM domain deletion, some full-
length protein could be observed, showing that the involved
protease is not able to fully process this truncate, either because
of the high overexpression or because this construct does not
localize to the inner membrane. Although we cannot exclude
that loop 5 is required for full functionality of the putative pro-
tease activity of MycP5, it is remarkable that this loop is only
present in a subset of MycP proteins, including MycP2 and
mycosins from plasmid-borne ESX systems (25).
The observation that the hybrid construct with the protease
domain of MycPP1 (Fig. 3, B, lane 9, P.P1-TM5, and C, lane 18)
of the ESX-P1 system and the TM domain of MycP5 also results
in successful complementation of the mycP5 knockout is not
very surprising, considering the high similarity of the two pro-
tease domains (Fig. S4 and Table S1). Interestingly, WT MycPP1
was not able to complement the mycP5 knockout, whereas its
presence did result in a small increase in ESX-5 complex levels.
ESX-5–mediated secretion was not observed, nor did this com-
plementation allow the bacterium to grow in the absence of
MspA. Although this again suggests an important role of the
TM domain in the system-specific functioning of MycP, we
cannot exclude that the observed different expression levels of
the proteases are responsible for the different phenotypes.
Finally, it is interesting to note that almost all tested con-
structs resulted in an “all-or-nothing” phenotype regarding
secretion. Except for the partial complementation of P5TM1,
which resulted in a strongly reduced growth rate of the bacte-
rium in the absence of MspA, secretion was either present or
absent in the complemented knockout strains of mycP1 and
mycP5. This is especially surprising, as we observed a high var-
iability in protein levels of the HA-tagged (hybrid or truncated)
mycP1 and mycP5 constructs. Apparently, only small amounts
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of mycosin are required to allow efficient secretion via the
ESX-1 and the ESX-5 membrane complex. Because we have
good indications that mycosins have a role in the stability of the
membrane complex (11), this could also imply that each bacte-
rium needs only a small number of active secretion machineries
to secrete substantial amounts of substrate. Furthermore, we
also observed that none of the successful complementations of
mycP1 resulted in a difference in the processing of EspB,
although this is not surprising, as we did not alter the catalytic
site in any of the mycP1 constructs.
Our combined results show that, instead of a highly defined
region, a major portion of mycosin, comprising both the prote-
ase and the TM domain, is involved in the essential role of
this component in ESX secretion, i.e. in the stabilization of
the respective ESX complex (for an overview, see Table S2).
As the protease domain of MycP1 is not functionally redun-
dant to MycP5, opposed to the protease domain of MyPP1,
this provides a starting point for future studies to identify the
regions and residues in the mycosin protease domain that
are involved in interacting with and stabilizing their respec-
tive ESX complex.
Experimental procedures
Bacterial strains and culture conditions
M. marinum M (26) was used for all M. marinum experi-
ments. The mycP1 and mycP5 knockout mutants of this strain
have been described previously by Ates et al. (6) and van Win-
den et al. (11). M. marinum was grown at 30 °C on 7H10 agar
with 10% Middlebrook OADC (BD Biosciences) or in Middle-
brook 7H9 liquid medium with 10% Middlebrook ADC and
with 0.05% Tween 80 at 30 °C and 150 rpm. M. smegmatis
MC2155 was used for all M. smegmatis experiments and was
grown at 37 °C on 7H10 agar with 10% Middlebrook OADC or
in Luria-Bertani (LB) liquid medium supplemented with 0.05%
Tween 80 at 150 rpm. E. coli strains DH5 and Rosetta were
grown at 37 °C on LB agar or in LB liquid medium at 37 °C and
200 rpm. Culture media were supplemented with the appropri-
ate antibiotics at the following concentrations: kanamycin, 25
g ml1; hygromycin, 50 g ml1; streptomycin, 35 g ml1;
ampicillin, 100 g ml1.
Cloning
The mycP1 and mycP5 M. marinum genes were amplified
from M. marinum M genomic DNA and mycPP1 from M. mari-
num E11 genomic DNA by PCR with anchored primers (EcoRI
and HindIII; Table S3). The active site mutant of mycP5 has
been created in a previous study (11). The hybrid combinations
of mycP1, mycP5, and mycPP1 point mutations and the HA tag
were introduced with nested primers (Table S3). All generated
constructs were subsequently digested by EcoRI and HindIII
and ligated into similarly digested pMV361 (27). The plasmids
used to express MycP1mth and EspBmtb have been described
previously by Wagner et al. (21). The mycP1mth construct was
modified with anchored (NdeI and XhoI) and nested primers
(Table S3) to create mycPmthloop1, which was ligated into
pET-28a following NdeI and XhoI digestion. All generated
plasmids were verified by sequencing of the cloned inserts.
M. marinum protein secretion and BN-PAGE analysis of ESX-5
complex
For protein secretion analysis, M. marinum strains were
grown in 7H9 liquid medium supplemented with 10% Middle-
brook ADC and 0.05% Tween 80 until mid-logarithmic phase
(A600 of 1–1.4), and then the cells were washed and inoculated
in 7H9 liquid medium containing 0.2% dextrose, 0.2% glycerol,
and 0.05% Tween 80 at an A600 of 0.5. After 16 h of growth, the
cells were pelleted (10 min at 3000  g), washed with PBS, and
resuspended in SDS loading buffer (pellet fraction). Superna-
tants were passed through an 0.45-m filter, and the proteins
were precipitated with TCA, washed with acetone, and resus-
pended in SDS loading buffer (supernatant fraction). Alterna-
tively, cell surface proteins were extracted from pelleted cells
with 0.5% Genapol X-080 as described previously (11), the
cells were repelleted and resuspended in SDS loading buffer
(Genapol pellet fraction), and concentrated SDS loading buffer
was added to the Genapol X-080 – containing supernatant
(Genapol supernatant fraction). Proteins from the various frac-
tions were separated on SDS-PAGE gels (with 10% to 16% acryl-
amide, depending on the size of the analyzed proteins), trans-
ferred to a nitrocellulose membrane, and stained with the
appropriate antibodies (see below). For both the secretion anal-
ysis and the HA expression blots, at least three colonies of each
strain were tested. The immunoblots used are an accurate rep-
resentation of the obtained, consistent results.
For ESX-5 complex analysis, M. marinum was grown to an
A600 of 1.2–1.5, pelleted, and resuspended in PBS with 250 mM
sucrose. Cells were lysed with a One-Shot Cell disruptor (Con-
stant Systems Ltd.), and unbroken cells were pelleted at 3000 
g. The cell envelope (CE) fraction was separated from the solu-
ble fraction by centrifugation at 200,000  g for 45 min, and the
CE fraction was subsequently resuspended in PBS with 250 mM
sucrose. Membrane proteins were extracted from the CE frac-
tion with the mild detergent dodecyl maltoside at a concentra-
tion of 0.25%. Solubilized protein (complexes) was either sepa-
rated under native conditions on a 3–12% NativePage Novex
BisTris Protein Gel (Life Technologies) and transferred to a
polyvinylidene difluoride membrane or under denaturing con-
ditions on a 12.5% SDS-PAGE gel, which was subsequently
transferred to a nitrocellulose membrane. Blots were stained
with anti-GroEL2 (Cs44; John Belisle, National Institutes of
Health, Bethesda, MD), anti-PE_PGRS (26), anti-EsxA/ESAT-6
(Mab Hyb76-8), anti-HA (HA.11, Covance, Biolegend), anti-
EccB5 (12, Colorado State University), anti-EspB (EPFL, Laus-
anne, Switzerland), anti-EccB1 (11), or anti-FtsH (28) antibod-
ies. Apart from the monoclonal anti-PE_PGRS and anti-EsxA
preparations, these are polyclonal rabbit antisera.
Protein expression, purification, and activity assays
His-tagged EspBmtb and MycP1mth were expressed and puri-
fied from E. coli Rosetta (DE3) as described previously by van
Winden et al. (11). MycP1 activity assays were performed in 20
mM HEPES (pH 7.5), 100 mM at 37 °C for 20 h with 0.15 mg
ml1 MycP1, and 0.25 mg ml1 EspB. Reactions were stopped
by addition of SDS sample buffer and incubation at 94 °C for 5
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min. Proteins were separated on a 12.5% SDS-PAGE gel and
visualized by Coomassie staining.
Author contributions—V. J. C. v. W., W. B., and E. N. G. H. concep-
tualization; V. J. C. v. W. and E. N. G. H. formal analysis; V. J. C. v. W.,
M. P. M. D., and R. U. investigation; V. J. C. v. W. visualization;
V. J. C. v. W., M. P. M. D., R. U., W. B., and E. N. G. H. methodology;
V. J. C. v. W. and E. N. G. H. writing-original draft; V. J. C. v. W.,
M. P. M. D., R. U., W. B., and E. N. G. H. writing-review and editing;
W. B. and E. N. G. H. supervision; E. N. G. H. project administration.
References
1. Abdallah, A. M., Gey van Pittius, N. C., Champion, P. A., Cox, J., Luirink,
J., Vandenbroucke-Grauls, C. M., Appelmelk, B. J., and Bitter, W. (2007)
Type VII secretion: mycobacteria show the way. Nat. Rev. Microbiol. 5,
883– 891 CrossRef Medline
2. Gey Van Pittius, N. C., Gamieldien, J., Hide, W., Brown, G. D., Siezen, R. J.,
and Beyers, A. D. (2001) The ESAT-6 gene cluster of Mycobacterium
tuberculosis and other high GC Gram-positive bacteria. Genome Biol. 2,
RESEARCH0044 Medline
3. Simeone, R., Bobard, A., Lippmann, J., Bitter, W., Majlessi, L., Brosch,
R., and Enninga, J. (2012) Phagosomal rupture by Mycobacterium tu-
berculosis results in toxicity and host cell death. PLoS Pathog. 8,
e1002507 CrossRef Medline
4. Pym, A. S., Brodin, P., Brosch, R., Huerre, M., and Cole, S. T. (2002) Loss of
RD1 contributed to the attenuation of the live tuberculosis vaccines My-
cobacterium bovis BCG and Mycobacterium microti. Mol. Microbiol. 46,
709 –717 CrossRef Medline
5. Siegrist, M. S., Unnikrishnan, M., McConnell, M. J., Borowsky, M., Cheng,
T.-Y., Siddiqi, N., Fortune, S. M., Moody, D. B., and Rubin, E. J. (2009)
Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisi-
tion. Proc. Natl. Acad. Sci. 106, 18792–18797 CrossRef Medline
6. Ates, L. S., Ummels, R., Commandeur, S., van de Weerd, R., Sparrius, M.,
Weerdenburg, E., Alber, M., Kalscheuer, R., Piersma, S. R., Abdallah,
A. M., Abd El Ghany, M., Abdel-Haleem, A. M., Pain, A., Jiménez, C. R.,
Bitter, W., and Houben, E. N. (2015) Essential role of the ESX-5 secretion
system in outer membrane permeability of pathogenic mycobacteria.
PLoS Genet. 11, e1005190 CrossRef Medline
7. van der Wel, N., Hava, D., Houben, D., Fluitsma, D., van Zon, M., Pierson,
J., Brenner, M., and Peters, P. J. (2007) M. tuberculosis and M. leprae trans-
locate from the phagolysosome to the cytosol in myeloid cells. Cell 129,
1287–1298 CrossRef Medline
8. Houben, D., Demangel, C., van Ingen, J., Perez, J., Baldeón, L., Abdallah,
A. M., Caleechurn, L., Bottai, D., van Zon, M., de Punder, K., van der Laan,
T., Kant, A., Bossers-de Vries, R., Willemsen, P., Bitter, W., et al. (2012)
ESX-1-mediated translocation to the cytosol controls virulence of myco-
bacteria. Cell. Microbiol. 14, 1287–1298 CrossRef Medline
9. Serafini, A., Boldrin, F., Palù, G., and Manganelli, R. (2009) Characteriza-
tion of a Mycobacterium tuberculosis ESX-3 conditional mutant: essenti-
ality and rescue by iron and zinc. J. Bacteriol. 191, 6340 – 6344 CrossRef
Medline
10. Houben, E. N., Bestebroer, J., Ummels, R., Wilson, L., Piersma, S. R., Jimé-
nez, C. R., Ottenhoff, T. H., Luirink, J., and Bitter, W. (2012) Composition
of the type VII secretion system membrane complex. Mol. Microbiol. 86,
472– 484 CrossRef Medline
11. van Winden, V. J. C., Ummels, R., Piersma, S. R., Jiménez, C. R., Korotkov,
K. V., Bitter, W., and Houben, E. N. G. (2016) Mycosins are required for
the stabilization of the ESX-1 and ESX-5 type VII secretion membrane
complexes. mBio 7, pii: e01471-16 CrossRef Medline
12. Wagner, J. M., Chan, S., Evans, T. J., Kahng, S., Kim, J., Arbing, M. A.,
Eisenberg, D., and Korotkov, K. V. (2016) Structures of EccB1 and EccD1
from the core complex of the mycobacterial ESX-1 type VII secretion
system. BMC Struct. Biol. 16, 5 CrossRef Medline
13. Rosenberg, O. S., Dovala, D., Li, X., Connolly, L., Bendebury, A., Finer-
Moore, J., Holton, J., Cheng, Y., Stroud, R. M., and Cox, J. S. (2015) Sub-
strates control multimerization and activation of the multi-domain AT-
Pase motor of type VII secretion. Cell 161, 501–512 CrossRef Medline
14. Beckham, K. S., Ciccarelli, L., Bunduc, C. M., Mertens, H. D., Ummels, R.,
Lugmayr, W., Mayr, J., Rettel, M., Savitski, M. M., Svergun, D. I., Bitter, W.,
Wilmanns, M., Marlovits, T. C., Parret, A. H., and Houben, E. N. (2017)
Structure of the mycobacterial ESX-5 type VII secretion system mem-
brane complex by single-particle analysis. Nat. Microbiol. 2, 17047
CrossRef Medline
15. Ohol, Y. M., Goetz, D. H., Chan, K., Shiloh, M. U., Craik, C. S., and Cox,
J. S. (2010) Mycobacterium tuberculosis MycP1 protease plays a dual role
in regulation of ESX-1 secretion and virulence. Cell Host Microbe 7,
210 –220 CrossRef Medline
16. Griffin, J. E., Gawronski, J. D., DeJesus, M. A., Ioerger, T. R., Akerley, B. J.,
and Sassetti, C. M. (2011) High-resolution phenotypic profiling defines
genes essential for mycobacterial growth and cholesterol catabolism. PLoS
Pathog. 7, e1002251 CrossRef Medline
17. Sassetti, C. M., Boyd, D. H., and Rubin, E. J. (2003) Genes required for
mycobacterial growth defined by high density mutagenesis. Mol. Micro-
biol. 48, 77– 84 CrossRef Medline
18. Houben, E. N., Korotkov, K. V., and Bitter, W. (2014) Take five: type
VII secretion systems of mycobacteria. Biochim. Biophys. Acta 1843,
1707–1716 CrossRef Medline
19. Brown, G. D., Dave, J. A., Gey van Pittius, N. C., Stevens, L., Ehlers, M. R.,
and Beyers, A. D. (2000) The mycosins of Mycobacterium tuberculosis
H37Rv: a family of subtilisin-like serine proteases. Gene 254, 147–155
CrossRef Medline
20. Solomonson, M., Huesgen, P. F., Wasney, G. A., Watanabe, N., Gruninger,
R. J., Prehna, G., Overall, C. M., and Strynadka, N. C. (2013) Structure of
the mycosin-1 protease from the mycobacterial ESX-1 protein type VII
secretion system. J. Biol. Chem. 288, 17782–17790 CrossRef Medline
21. Wagner, J. M., Evans, T. J., Chen, J., Zhu, H., Houben, E. N., Bitter, W., and
Korotkov, K. V. (2013) Understanding specificity of the mycosin proteases
in ESX/type VII secretion by structural and functional analysis. J. Struct.
Biol. 184, 115–128 CrossRef Medline
22. Sun, D., Liu, Q., He, Y., Wang, C., Wu, F., Tian, C., and Zang, J. (2013) The
putative propeptide of MycP1 in mycobacterial type VII secretion system
does not inhibit protease activity but improves protein stability. Protein
Cell 4, 921–931 CrossRef Medline
23. Faller, M., Niederweis, M., and Schulz, G. E. (2004) The structure
of a mycobacterial outer-membrane channel. Science 303, 1189 –1192
CrossRef Medline
24. Ummels, R., Abdallah, A. M., Kuiper, V., Aâjoud, A., Sparrius, M., Naeem,
R., Spaink, H. P., van Soolingen, D., Pain, A., and Bitter, W. (2014) Identi-
fication of a novel conjugative plasmid in mycobacteria that requires both
type IV and type VII secretion. mBio 5, e01744-14 CrossRef Medline
25. Dumas, E., Boritsch, E. C., Vandenbogaert, M., Rodríguez de la Vega, R. C.,
Thiberge, J. M., Caro, V., Gaillard, J. L., Heym, B., Girard-Misguich, F.,
Brosch, R., and Sapriel, G. (2016) Mycobacterial pan-genome analysis sug-
gests important role of plasmids in the radiation of type VII secretion
systems. Genome Biol. Evol. 8, 387– 402 CrossRef Medline
26. Abdallah, A. M., Verboom, T., Hannes, F., Safi, M., Strong, M., Eisenberg,
D., Musters, R. J., Vandenbroucke-Grauls, C. M., Appelmelk, B. J., Luirink,
J., and Bitter, W. (2006) A specific secretion system mediates PPE41 trans-
port in pathogenic mycobacteria. Mol. Microbiol. 62, 667– 679 CrossRef
Medline
27. Stover, C. K., de la Cruz, V. F., Fuerst, T. R., Burlein, J. E., Benson, L. A.,
Bennett, L. T., Bansal, G. P., Young, J. F., Lee, M. H., Hatfull, G. F., Snapper,
S. B., Barletta, R. G., Jacobs, W. R., and Bloom, B. R. (1991) New use of BCG
for recombinant vaccines. Nature 351, 456 – 460 CrossRef Medline
28. van Bloois, E., Dekker, H. L., Fröderberg, L., Houben, E. N., Urbanus, M. L.,
de Koster, C. G., de Gier, J. W., and Luirink, J. (2008) Detection of cross-
links between FtsH, YidC, HflK/C suggests a linked role for these proteins
in quality control upon insertion of bacterial inner membrane proteins.
FEBS Lett. 582, 1419 –1424 CrossRef Medline
Protease domain and TM domain mediate MycP system specificity
























Vincent J. C. van Winden, Merel P. M. Damen, Roy Ummels, Wilbert Bitter and Edith
protease determine system-specific functioning in mycobacteria
Protease domain and transmembrane domain of the type VII secretion mycosin
doi: 10.1074/jbc.RA118.007090 originally published online January 28, 2019
2019, 294:4806-4814.J. Biol. Chem. 
  
 10.1074/jbc.RA118.007090Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/294/13/4806.full.html#ref-list-1
This article cites 28 references, 4 of which can be accessed free at
 at V
R
IJE
 U
N
IV
E
R
SIT
E
IT
 on N
ovem
ber 13, 2020
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
